Horwich, A <br/><br/>
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.  [electronic resource] 

 -  British journal of cancer  Dec 2000 
 - 1623-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1054/bjoc.2000.1498  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--adverse effects<br/>Cisplatin--administration & dosage<br/>Etoposide--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Neutropenia--chemically induced<br/>Seminoma--drug therapy<br/>Survival Analysis<br/>Testicular Neoplasms--drug therapy<br/>Thrombocytopenia--chemically induced<br/>Time Factors<br/>Treatment Outcome